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Introduction
Transport of most secretory proteins to the extracellular space
is mediated by the ER/Golgi-dependent secretory pathway
(Palade, 1975; Rothman, 1994; Rothman and Wieland, 1996;
Nickel et al., 2002). In the case of soluble factors, the principal
targeting motifs are N-terminal signal peptides that direct
classical secretory proteins to the translocation machinery of
the ER (Keenan et al., 2001). However, for a number of soluble
factors with defined extracellular functions, it has been
demonstrated that ER/Golgi-independent routes of protein
secretion exist (Muesch et al., 1990; Rubartelli and Sitia, 1991;
Cleves, 1997; Hughes, 1999; Nickel, 2003; Prudovsky et al.,
2003). Among these, the most prominent examples are the
angiogenic growth factors FGF-1 (Jackson et al., 1992;
Jackson et al., 1995; Shin et al., 1996; LaVallee et al., 1998;
Tarantini et al., 1998; Landriscina et al., 2001a; Landriscina et
al., 2001b; Prudovsky et al., 2002; Mandinova et al., 2003) and
FGF-2 (Mignatti and Rifkin, 1991; Mignatti et al., 1992;
Florkiewicz et al., 1995; Trudel et al., 2000; Engling et al.,
2002), cytokines like interleukin 1β (IL1β) (Rubartelli et al.,
1990; Andrei et al., 1999; Andrei et al., 2004) and migration
inhibitory factor (MIF) (Flieger et al., 2003) as well as the
galectin protein family, lectins of the extracellular matrix
(Cooper and Barondes, 1990; Cleves et al., 1996; Lutomski et
al., 1997). These and other unconventional secretory proteins
are characterized by the lack of a signal peptide, by not being
glycosylated (despite bearing multiple consensus sites for this
post-translational modification) and, most importantly, by an
export mechanism that is fully functional in the presence of
brefeldin A (Cleves, 1997; Hughes, 1999; Nickel, 2003), a drug
that blocks ER/Golgi-dependent protein transport (Misumi et
al., 1986; Lippincott-Schwartz et al., 1989; Orci et al., 1991).
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Leishmania HASPB is a lipoprotein that is exported to the
extracellular space from both Leishmania parasites and
mammalian cells via an unconventional secretory pathway.
Exported HASPB remains anchored in the outer leaflet
of the plasma membrane mediated by myristate and
palmitate residues covalently attached to the N-terminal
SH4 domain of HASPB. HASPB targeting to the plasma
membrane depends on SH4 acylation that occurs at
intracellular membranes. How acylated HASPB is targeted
to the plasma membrane and, in particular, the subcellular
site of HASPB membrane translocation is unknown. In
order to address this issue, we screened for clonal CHO
mutants that are incapable of exporting HASPB. A detailed
characterization of such a CHO mutant cell line revealed
that the expression level of the HASPB reporter molecule
is unchanged compared to CHO wild-type cells; that it is
both myristoylated and palmitoylated; and that it is mainly
localized to the plasma membrane as judged by confocal
microscopy and subcellular fractionation. However, based
on a quantitative flow cytometry assay and a biochemical
biotinylation assay of surface proteins, HASPB transport
to the outer leaflet of the plasma membrane is largely
reduced in this mutant. From these data, we conclude that
the subcellular site of HASPB membrane translocation
is the plasma membrane as the reporter molecule
accumulates in this location when export is blocked. Thus,
these results allow us to define a two-step process of HASPB
cell surface biogenesis in which SH4 acylation of HASPB
firstly mediates intracellular targeting to the plasma
membrane. In a second step, the plasma membrane-
resident machinery, which is apparently disrupted in the
CHO mutant cell line, mediates membrane translocation of
HASPB. Intriguingly, the angiogenic growth factor FGF-2,
another protein secreted by unconventional means, is
shown to be secreted normally from the HASPB export
mutant cell line. These observations demonstrate that the
export machinery component defective in the export
mutant cell line functions specifically in the HASPB export
pathway.
Key words: Leishmania parasites, Surface coat, Hydrophilic acylated
surface protein, Acylation, SH4 domain, Cell surface expression,
Non-classical protein export, Fibroblast growth factor 2
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Leishmania HASPB is another interesting kind of
unconventional secretory protein that is a component of the
surface coat of Leishmania parasites (Flinn et al., 1994;
McKean et al., 1997; Alce et al., 1999). HASPB is exclusively
expressed in infective parasites in both extracellular
metacyclics and intracellular amastigotes of L. major and L.
donovani (Rangarajan et al., 1995; McKean et al., 1997; Alce
et al., 1999) suggesting a role in parasite virulence, although
gene deletion mutants retain their viability in the host (McKean
et al., 2001). Intriguingly, following heterologous expression,
HASPB is also externalized by mammalian cells (Denny et al.,
2000) suggesting that endogenous factors exist in higher
eukaryotes that are exported in a mechanistically similar
manner.
HASPB contains an N-terminal SH4 domain that becomes
dually acylated by myristoylation of glycine 2 and
palmitoylation of cysteine 5 (Denny et al., 2000). These post-
translational modifications are essential for HASPB targeting to
the cell surface of Leishmania parasites (Pimenta et al., 1994;
Denny et al., 2000). Interestingly, the extreme N-terminus of
HASPB (HASPB-N18) is sufficient for targeting of HASPB-
N18-GFP to the cell surface (Denny et al., 2000). A
myristoylated HASPB mutant that cannot be palmitoylated
(HASPBC5S-GFP) has been found to localize to Golgi
membranes (Denny et al., 2000) suggesting that HASPB
associates at least transiently with membranes of the
classical secretory pathway. Therefore, even though
palmitoylacyltransferase activities have not only been localized
to the Golgi but also to the ER and plasma membranes
(reviewed by Bijlmakers and Marsh, 2003), it is likely that
transfer of palmitate to the SH4 domain of HASPB occurs at
the Golgi. Following palmitoylation, HASPB is transferred to
the plasma membrane but the mechanism of this transport
process is unknown. Interestingly, HASPB surface expression
in mammalian cells is not affected by brefeldin A (Denny et al.,
2000), making it unlikely that dually acylated HASPB reaches
the plasma membrane bound to the cytoplasmic leaflet of
secretory vesicles. Based on these considerations, HASPB
trafficking appears to be distinct from all three known classes
of plasma membrane-targeted proteins carrying dual acylation
motifs at their N-termini (Bijlmakers and Marsh, 2003). The
first of these, the Src kinase Lck, is palmitoylated at the Golgi
followed by brefeldin A-sensitive transport to the plasma
membrane (Bijlmakers and Marsh, 1999; Bijlmakers and
Marsh, 2003). Secondly, Gαζ subunits of plasma membrane-
resident trimeric G proteins are transiently associated with
intracellular membranes like Lck, but these factors get
palmitoylated at the plasma membrane and transport to this site
is fully operational in the presence of brefeldin A (Fishburn
et al., 1999; Bijlmakers and Marsh, 2003). Finally, a third
mechanism of plasma membrane targeting of N-terminally
acylated proteins is exemplified by the Src kinase Fyn that does
not appear to contact intracellular membranes but rather is
directly targeted from the cytoplasm to the plasma membrane.
Consistently, brefeldin A does not affect Fyn targeting (van’t
Hof and Resh, 1997; Bijlmakers and Marsh, 2003). As indicated
above, current knowledge about HASPB targeting to the plasma
membrane does not fit with any of these examples as HASPB
is transiently associated with, and most likely palmitoylated at,
the Golgi followed by plasma membrane targeting in a brefeldin
A-insensitive manner (Denny et al., 2000).
Based on these considerations, many questions about the
molecular mechanism of HASPB targeting to the plasma
membrane remain unresolved. There is also a complete lack of
knowledge about the subcellular site of membrane translocation
of HASPB, a process that eventually allows HASPB exposure
on the cell surface of eukaryotic cells. In the current study, we
introduce a novel experimental system that permits the precise
quantification of HASPB export from mammalian cells based
on flow cytometry. Using this assay, we screened for somatic
CHO mutants that are incapable of exporting HASPB-GFP
fusion protein employing retroviral insertion mutagenesis.
Based on a detailed biochemical and morphological
characterization of a mutant with this phenotype, we conclude
that the site of HASPB membrane translocation is the plasma
membrane. These data suggest that in the CHO mutant
described, a component of a plasma membrane-resident
machinery has been disrupted causing the fully acylated
HASPB-GFP reporter molecule to accumulate in the inner
leaflet of the plasma membrane. These results support a two-
step process of HASPB biogenesis, in which dual acylation of
the HASPB SH4 domain is required for delivery to the inner
leaflet of the plasma membrane and subsequent recognition by
a putative translocation machinery. Intriguingly, the component
of the HASPB export apparatus that has been disrupted in the
mutant cell line appears to be specific for this export pathway,
as the angiogenic growth factor FGF-2, another protein secreted
by unconventional means, is found to be exported normally
from the HASPB export mutant cell line.
Materials and Methods
Antibodies
Affinity-purified anti-GFP antibodies were generated as described
earlier (Engling et al., 2002; Seelenmeyer et al., 2003). Antibodies
directed against the transferrin receptor were from Zymed, antibodies
directed against GM130 were purchased from BD Transduction
Laboratories. Monoclonal anti-CD4 antibodies were obtained from
cell culture supernatants of the hybridoma cell line Okt4 (ATCC CRL-
8002). APC-conjugated anti-rabbit and anti-mouse IgG antibodies
used for FACS analyses were from Molecular Probes.
Generation of HASPB-GFP fusion protein expressing cell lines
All HASPB fusion proteins used in this study are based on enhanced
GFP (Clontech). The 18 N-terminal amino acids of HASPB
(MGSSCTKDSAKEPQKRAD) were fused to the N-terminus of
eGFP through a short linker sequence (GPVAT). In case of HASPB-
N18-GFP ∆myr/palm and HASPB-N18-GFP ∆palm, two single
amino acid changes were introduced to prevent myristoylation and
palmitoylation (G2A), and palmitoylation (C5S), respectively. All
constructs were cloned into the retroviral expression vector pREV-
TRE2 that contains a doxicycline-dependent promoter. Generation of
CHO cell lines expressing the various HASPB fusion proteins
employing retroviral transduction was performed as described
previously (Engling et al., 2002).
Biochemical analysis of membrane association of HASPB-
GFP fusion proteins
CHO cells expressing the various kinds of HASPB-GFP fusion
proteins were cultured for 2 days at 37°C in the presence of doxicycline
(1 µg/ml). Following detachment using PBS/EDTA, cells were
collected by centrifugation (500 g, 5 minutes) and resuspended in
PBS/sucrose (10% w/w) homogenization buffer. Cells were broken up
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by sonication and then ultracentrifuged for 60 minutes at 100,000 g.
The resulting supernatant was defined as the cytosolic fraction, the
sediment was resuspended in homogenization buffer and defined as the
membrane fraction. For carbonate extraction experiments, membranes
were again collected by ultracentrifugation. Following resuspension in
Na2CO3 (0.1 M, pH 11.5), the samples were incubated for 30 minutes
at 4°C. Membranes were re-isolated by ultracentrifugation and
separated into supernatant (peripheral membrane proteins) and
membrane sediment (integral and tightly associated proteins).
Metabolic labeling of CHO cells using [3H]myristate and
[3H]palmitate
CHO cells expressing HASPB-GFP fusion proteins were grown on
six-well plates for 48 hours at 37°C in the presence of doxicycline (1
µg/ml) to about 80% confluency. Following 2 hours of incubation
in FCS-free medium, cells were incubated in FCS-free medium
containing either 250 µCi [3H]palmitic acid or 100 µCi [3H]myristic
acid. After 3 hours of incubation in labeling medium at 37°C, cells
were washed and lysed in buffer containing detergent by sonication.
Following removal of insoluble material by centrifugation (14,000 g,
10 minutes), the lysates were subjected to immunoprecipitation of
HASPB-GFP fusion proteins employing affinity-purified anti-GFP
antibodies. Antibody-bound protein was eluted with SDS sample
buffer and subjected to SDS-PAGE. For this purpose, the samples
were split into two fractions in order to analyze the eluted proteins by
both fluorography and silver staining. For fluorography, SDS gels
were treated with NAMP100 amplifier solution (Amersham) and then
dried for exposure using HyperfilmTM (Amersham). Typically, SDS
gels containing [3H]myristic acid-labeled proteins were exposed for
about 2 weeks whereas SDS gels containing [3H]palmitic acid-labeled
proteins were exposed for up to 6 weeks.
Confocal microscopy
CHO cells expressing HASPB-GFP fusion proteins were grown on
glass cover slips for 48 hours at 37°C in the presence of 1 µg/ml
doxicyclin. The cells were then processed including
paraformaldehyde fixation (3% w/v) for 20 minutes at 4°C. The
specimens were mounted in Fluoromount G (Southern Biotechnology
Associates) and GFP-derived fluorescence was viewed with a Zeiss
LSM 510 confocal microscope.
Fluorescence-activated cell sorting
CHO cells expressing HASPB-GFP fusion proteins were grown under
the conditions indicated in the corresponding figure legends. In order
to detach the cells from the culture plates without using protease-
based protocols, cell dissociation buffer (Life Technologies) was used
to generate a cell suspension devoid of cell aggregates. Where
indicated, cells were treated with affinity-purified anti-GFP antibodies
for 1 hour at 4°C on a rotating wheel. Wash procedures were carried
out by sedimenting the cells at 200 g for 3 minutes at 4°C. Primary
antibodies were detected with goat anti-rabbit secondary antibodies
coupled to allophycocyanin (APC; Molecular Probes). Prior to FACS
analysis, propidium iodide (1 µg/ml) was added in order to detect
damaged cells. GFP- and APC-derived fluorescence was analyzed
using a Becton Dickinson FACSCalibur flow cytometer.
Autofluorescence was determined by measuring non-induced cells
that were treated with primary and APC-coupled secondary
antibodies. FACS-mediated isolation of cell populations and clones
was performed using a Becton Dickinson FACSVantage cell sorter.
Biochemical analysis of cell surface-associated HASPB-GFP
fusion proteins
CHO cells expressing HASPB-GFP fusion proteins were grown under
the conditions indicated in the corresponding figure legends.
Following removal of the medium, the cells were washed twice with
PBS containing Ca2+ and Mg2+ (2 mM each). A membrane-
impermeable biotinylation reagent (EZ-Link Sulfo-NHS-SS-biotin;
Pierce) dissolved in 10 mM triethanolamine, 150 mM NaCl and 2 mM
CaCl2 (pH 9) was added at a final concentration of 1 mg/ml. Following
incubation for 30 minutes at 4°C quenching of excess amounts of
biotinylation reagent was achieved by adding 100 mM PBS/glycine.
The cells were then washed twice with PBS containing 2 mM Ca2+
and Mg2+. Cell lysates were prepared by adding PBS containing NP-
40. Cell lysates were cleared by centrifugation and biotinylated and
non-biotinylated proteins were separated by streptavidin affinity
chromatography. The two fractions were probed for the presence of
HASPB-GFP fusion proteins using SDS-PAGE and western blotting
with affinity-purified anti-GFP antibodies.
Retroviral insertion mutagenesis and FACS-based isolation of
HASPB export mutants
To randomly mutate CHO cells, we prepared retroviral particles
encoding the cell surface protein CD4 (pBI-CD4) (Liu et al., 2000)
using the Viraport system (Stratagene). CHO cells expressing
HASPB-N18-GFP were transduced according to standard procedures.
Following 3 days of incubation at 37°C CD4-positive cells were
selected by FACS sorting. In order to isolate HASPB export mutants
CD4-positive cells were subjected to multiple rounds of FACS sorting,
selecting for cells with high GFP fluorescence and low cell surface
staining. In the third round of FACS sorting, individual cells were
collected and further propagated in 96-well plates at 37°C. The
corresponding clonal cell lines were then characterized as described.
Results
Generation of model cell lines to study HASPB export
from mammalian cells
In order to study the export mechanism of HASPB on a
quantitative basis in mammalian cells, we generated CHO cells
that express various kinds of HASPB-GFP fusion proteins in
a doxicycline-dependent manner. CHOMCAT-TAM2 cells (Engling
et al., 2002) were transduced with retroviruses carrying
HASPB-N18-GFP, HASPB-N18-GFP-∆palm (C5S), HASPB-
N18-GFP-∆myr/palm (G2A) or GFP, respectively. Clonal cell
lines were obtained by several rounds of FACS sorting in the
absence and presence of doxicycline, respectively, followed by
the selection of single cells characterized by GFP-derived
fluorescence only after the addition of doxicycline. As shown
in Fig. 1A, expression of the various reporter molecules could
only be detected following incubation of the cells with
doxicycline as analyzed by western blotting employing anti-
GFP antibodies.
Characterization of HASPB fusion protein-expressing
model cell lines
We then tested the overall membrane association of the various
HASPB fusion proteins by subcellular fractionation into a
soluble pool (referred to as ‘cytosol’; Fig. 1B, lane 1) and
a membrane fraction (Fig. 1B, lane 2). Additionally, the
membrane fraction was subjected to carbonate extraction
(Fujiki et al., 1982) to discriminate loosely attached material
(Fig. 1B, lane 3) from protein tightly associated with
membranes (Fig. 1B, lane 4). Typically roughly equal amounts
of HASPB-N18-GFP were found in the cytosolic and the
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membrane fractions. About two thirds of the membrane-bound
material was found to be resistant to carbonate treatment. In
the case of HASPB-N18-GFP-∆palm (C5S), as expected, the
population found in the cytosolic fraction was significantly
larger than that present in the membrane fraction (Fig. 1B).
About 50% of membrane-associated HASPB-N18-GFP-∆palm
was found to be resistant to carbonate treatment. The vast
majority of HASPB-N18-GFP-∆myr/palm (G2A), a mutant
that lacks both myristoylation and palmitoylation, was found
in the cytosolic fraction which is also the case for GFP lacking
the HASPB-N18 sequence (Fig. 1B). Thus, subcellular
fractionation combined with carbonate extraction allows
analysis of the acylation status of HASPB fusion proteins.
We next analyzed the subcellular distribution of the
HASPB-GFP fusion proteins employing confocal microscopy
(Fig. 2). HASPB-N18-GFP was found to localize mainly to
the plasma membrane as well as to droplet-like structures that
were typically located in close proximity to the plasma
membrane (Fig. 2A). By contrast, HASPB-N18-GFP-∆palm
was not at all associated with the plasma membrane but was
rather localized on intracellular membranes in a perinuclear
position (Fig. 2B). As expected, HASPB-N18-GFP-
∆myr/palm was found exclusively in the cytoplasm (Fig. 2C)
with a staining pattern indistinguishable from that of GFP
(Fig. 2D). Thus, membrane association of HASPB-GFP is
completely dependent on dual acylation of the HASPB N-
terminus. These results are consistent with previous studies
analyzing similar constructs in Leishmania parasites (Denny
et al., 2000).
Functional analysis of HASPB export from CHO cells
based on quantitative flow cytometry
Based on previous observations (Denny et al., 2000), an export
assay was developed that simultaneously measures both the
expression level of a given HASPB-GFP fusion protein and its
export to the outer leaflet of the plasma membrane on a
quantitative basis. Following membrane translocation,
HASPB-GFP fusion proteins remain membrane-anchored
through their acylated N-termini, allowing decoration of the
extracellular population with anti-GFP antibodies. This
subpopulation is then specifically detected using APC-
conjugated secondary antibodies. Using flow cytometry, GFP-
Journal of Cell Science 118 (3)
Fig. 1. Expression level and membrane association of HASPB-
GFP fusion proteins expressed in CHO cells. (A) CHO cells
expressing HASPB-GFP fusion proteins as indicated were grown
on six-well plates in the absence (lanes 1, 3, 5 and 7) or presence
(lanes 2, 4, 6 and 8) of 1 µg/ml doxicycline (dox). Cells were
detached and collected by centrifugation followed by lysis in SDS
sample buffer. 1% of each lysate corresponding to cells from one
well were subjected to SDS-PAGE. Following SDS-PAGE and
western blotting HASPB-GFP fusion proteins were detected using
affinity-purified anti-GFP antibodies. (B) CHO cells expressing
HASPB-GFP fusion proteins as indicated were fractionated into
cytosolic (lane 1) and membrane fractions (lane 2). Additionally,
the membrane fraction was subjected to carbonate extraction
resulting in a carbonate supernatant containing loosely bound
proteins (lane 3) and a carbonate pellet containing proteins tightly
associated with membranes (lane 4). 5% of each fraction was
combined with SDS sample buffer and proteins were separated by
SDS-PAGE. Following western blotting, HASPB-GFP fusion
proteins were detected with affinity-purified anti-GFP antibodies.
Fig. 2. Subcellular distribution of HASPB-GFP fusion proteins as
determined by confocal microscopy. Cells were grown on glass
coverslips in the presence of 1 µg/ml doxicycline for 48 hours at 37°C.
GFP-derived fluorescence was viewed with a Zeiss LSM 510 confocal
microscope. (A) HASPB-N18-GFP; (B) HASPB-N18-GFP-∆palm; (C)
HASPB-N18-GFP-∆myr/palm; (D) GFP. 
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derived fluorescence (overall expression level) and APC-
derived fluorescence (exported population) is measured
simultaneously. All three HASPB-GFP fusion proteins as well
as GFP lacking an N-terminal HASPB tag are expressed at
similar levels provided that the cells have been treated with
doxicycline (Fig. 3A). Only the expression of HASPB-N18-
GFP gives rise to surface staining whereas HASPB-N18-GFP-
∆palm, HASPB-N18-GFP-∆palm/myr and GFP are negative
with regard to cell surface staining (Fig. 3B). Again, these data
are consistent with previous observations made in parasites
(Denny et al., 2000) in that export to the extracellular leaflet
of the plasma membrane of mammalian cells is critically
dependent on dual acylation of the SH4 N-terminus of HASPB.
Thus, the in vivo assay introduced in Fig. 3 allows precise
quantification of HASPB export under normalized conditions
with respect to the expression level of a given HASPB-GFP
fusion protein.
Biochemical analysis of HASPB-N18-GFP export to the
outer leaflet of the plasma membrane of CHO cells
In order to demonstrate an external population of HASPB-
N18-GFP associated with the outer leaflet of the plasma
membrane using an independent method, biotinylation
experiments were carried out employing a membrane-
impermeable biotinylation reagent. Cells were incubated in
the presence of doxicycline, serum-containing medium was
removed followed by treatment with a biotinylation reagent.
After quenching and removing excess amounts of the
biotinylation reagent, cells were converted into a detergent
lysate that was then subjected to streptavidin affinity
chromatography to separate biotinylated (cell surface) from
non-biotinylated (intracellular) proteins. HASPB-N18-GFP
can be detected in the fraction eluted from streptavidin beads
(Fig. 4, lane 3) whereas the various controls (HASPB-N18-
GFP-∆palm, HASPB-N18-GFP-∆myr/palm and GFP) are
absent from this fraction. These results demonstrate that the
biotinylation reagent does not traverse the plasma membrane
and, therefore, the positive signal for HASPB-N18-GFP in the
fraction of biotinylated proteins represents a population
located on the surface of these cells. Under steady-state
conditions, the amount of HASPB-N18-GFP on the surface of
CHO cells was calculated by densitometry to vary between
experiments within a range of ~3-6% of the overall population
(data not shown).
Screening for somatic CHO mutants characterized by a
defect in HASPB export
The principal aim of this study was to identify the subcellular
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Fig. 3. Quantitative analysis of cell surface localized HASPB-GFP
fusion proteins using flow cytometry. (A) GFP-derived fluorescence
(expression level). (B) APC-derived fluorescence (cell surface
staining). Cells were incubated in the presence or absence of
doxicycline as indicated followed by processing for FACS sorting.
HASPB-N18-GFP, light and dark blue curves; HASPB-N18-GFP-
∆palm, yellow and orange curves; HASPB-N18-GFP-∆myr/palm,
light and dark green curves; GFP, light and dark red curves.
Fig. 4. Biochemical quantification of cell surface localized HASPB-
GFP fusion proteins. CHO cells expressing HASPB-GFP fusion
proteins as indicated were treated with a membrane-impermeable
biotinylation reagent. Cell lysates were generated and biotin-labeled
and biotin-unlabeled proteins were separated by streptavidin affinity
chromatography. Input material (lane 1; 2%), streptavidin
supernatant (non-biotinylated proteins, lane 2; 2%) and streptavidin-
bound proteins (biotinylated proteins, lane 3; 50%) were separated
on SDS gels followed by western blotting using affinity-purified anti-
GFP antibodies.
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site of HASPB membrane translocation in CHO cells. To
address this point, we generated clonal CHO mutants by
retroviral insertion mutagenesis, which are characterized by a
negative HASPB export phenotype. In order to make sure that
such mutants can be identified in the presence of wild-type
cells, we first conducted experiments designed to detect
intercellular spreading of HASPB-N18-GFP following
translocation onto the cell surface. For this purpose, HASPB-
N18-GFP-expressing and HASPB-N18-GFP-non-expressing
cells (CHOMCAT-TAM2) were mixed in culture, treated with
doxicycline and subjected to a FACS analysis measuring GFP
and APC-derived cell surface fluorescence. Two populations of
cells from a mixed culture of CHOMCAT-TAM2 cells (Fig. 5A,
green curve) (negative for GFP fluorescence, data not shown)
and HASPB-N18-GFP-expressing cells (blue curve) (positive
for GFP fluorescence, data not shown) can be easily
distinguished by anti-GFP cell surface staining, demonstrating
that HASPB-N18-GFP-exporting cells retain the secreted
material on their surface. However, cell surface staining of
HASPB-N18-GFP-non-expressing cells is in fact significantly
higher than the autofluorescence background defined by
antibody-treated CHOMCAT-TAM2 cells (Fig. 5A, red curve),
suggesting that a certain amount of HASPB-N18-GFP was
transferred from HASPB-N18-GFP-expressing cells to non-
expressing cells. This observation emphasizes the conclusions
drawn from the experiments shown in Figs 3 and 4, in that an
extracellular population of HASPB-N18-GFP can be defined
by its appearance on the surface of cells that are incapable of
expressing the reporter molecule when mixed with HASPB-
N18-GFP-expressing cells. With regard to the mutagenesis
strategy, however, these experiments demonstrate that HASPB
export mutants are distinguishable from wild-type cells on the
basis of FACS sorting and can therefore be identified and
isolated by this method, even in the presence of a large excess
of wild-type cells.
To randomly generate somatic CHO mutants, we chose
retroviral insertion mutagenesis. CHO cells carrying the
HASPB-N18-GFP reporter gene were transduced with
retroviral particles encoding the open reading frame of the
integral plasma membrane protein CD4 (Fig. 5B) (Liu et al.,
2000). In this context, CD4 was used as a marker for mutated
cells that were subsequently enriched by FACS. The pool of
CD4-positive mutated cells (Fig. 5B, blue curve) was then
subjected to a selection of CHO mutants expressing the
HASPB-N18-GFP reporter molecule at a normal level (as
compared to wild-type cells) but without localisation to the cell
surface. For this purpose, cells were viewed in the FACS set-
up in dot blot mode and a sorting window was defined to select
for the phenotype described (Fig. 5C). Cells isolated from this
window in the first round of sorting (about 0.5% of the total
population) were propagated and subjected to a second round
of cell sorting in which 3.7% of the selected population
displayed the desired phenotype. In a third round of cell
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Fig. 5. Retroviral insertion mutagenesis of CHO cells and genetic
screening for HASPB export mutants. (A) Intercellular spreading
was monitored by growing CHOMCAT-TAM2 cells (‘CHO wild type’)
with CHOMCAT-TAM2 cells retrovirally transduced with the HASPB-
N18-GFP construct in a mixed culture. HASPB-N18-GFP expression
was induced by 1 µg/ml doxicycline for 48 hours at 37°C. Cells were
then processed for FACS sorting using affinity-purified anti-GFP
antibodies and APC-coupled secondary antibodies to detect exported
HASPB-N18-GFP by cell surface staining. CHOMCAT-TAM2 cells and
CHOMCAT-TAM2 cells expressing HASPB-N18-GFP were gated based
on GFP fluorescence and APC-derived fluorescence of
CHOMCAT-TAM2 cells (green curve) and CHOMCAT-TAM2 cells
expressing HASPB-N18-GFP (blue curve) was measured as depicted
in the histogram. Autofluorescence was measured using
CHOMCAT-TAM2 cells that were treated with antibodies.
(B) CHOMCAT-TAM2 cells expressing HASPB-N18-GFP were treated
with retroviral particles encoding the cell surface protein CD4.
Following transduction, CD4-positive cells were selected based on
anti-CD4 cell surface staining using FACS sorting. (C) CD4-positive
cells as enriched in the FACS experiment depicted in B were
subjected to three rounds of FACS sorting. Cells were monitored in
dot blot mode with GFP-derived fluorescence shown on the y-axis
and HASPB-N18-GFP cell surface staining shown on the x-axis. The
left-hand panel shows the population grown in the absence of
doxicycline, the right-hand panel shows the population grown in the
presence of 1 µg/ml doxicycline for 48 hours at 37°C. To select for
HASPB export mutants the sorting window was adjusted as depicted
in the right-hand panel to isolate cells characterized by high GFP
fluorescence and low APC cell surface staining.
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sorting, single cells were selected in the
sorting window (defined in Fig. 5C).
Characterization of a clonal CHO
mutant cell line defective in HASPB
export
In the current study, we provide a detailed
characterization of a clonal CHO cell line
(from here on referred to as ‘K3’) derived
from the selection procedure of the
experiments described in Fig. 5. In order
to make sure that the reporter molecule
itself does not contain a mutation in the
CHO K3 mutant cell line, we isolated
genomic DNA and amplified the HASPB-
N18-GFP open reading frame. As
demonstrated by sequencing of the
corresponding PCR product, the sequence
of the N-terminal SH4 domain of the
reporter molecule was confirmed to be
unchanged compared to the parental CHO
wild-type cells (data not shown).
Based on GFP-derived fluorescence, the
expression level of HASPB-N18-GFP
does not significantly differ between wild-
type and K3 cells as analyzed by FACS
(Fig. 6A). However, HASPB-N18-GFP
cell surface staining is largely reduced to
about 30% as compared to wild-type levels
(Fig. 6A). These data were confirmed by a
biochemical assessment of the
extracellular population of HASPB-N18-
GFP in the wild type compared to K3
mutant cells using the biotinylation assay
described in Fig. 4. The amount of
biotinylated cell surface HASPB-N18-
GFP (Fig. 6B, upper panel; lane 3) derived from K3 cells is
reduced to about 20% when compared to CHO wild-type cells
(lower panel; lane 3).
As dual acylation of HASPB-N18-GFP is a critical
determinant for plasma membrane targeting and export, it was
important to analyze whether the reporter molecule HASPB-
N18-GFP itself is properly modified in CHO K3 cells.
Therefore, in a first set of experiments, overall membrane
association of HASPB-N18-GFP was tested in CHO K3 cells
by a carbonate extraction analysis. The input material of
HASPB-N18-GFP was comparable in wild-type CHO and K3
cells, which is consistent with the FACS experiments shown in
Fig. 6, demonstrating that the expression level of HASPB-N18-
GFP does not differ significantly in the two cell lines (Fig. 7A).
Similarly, there are no apparent differences in the distribution
of HASPB-N18-GFP between cytosol and membranes when
CHO wild-type and K3 cells are compared (Fig. 7B, lanes 1
and 2). Finally, when the membrane fractions of wild-type and
K3 cells were subjected to carbonate extraction, the
distribution of HASPB-N18-GFP between the membrane-
associated and the soluble pool was identical between the two
cell types (Fig. 7B, lanes 3 and 4). These data suggest that the
acylation status of HASPB-N18-GFP does not differ between
CHO wild-type and K3 cells. This conclusion was confirmed
by metabolic labeling of HASPB-N18-GFP in wild-type and
K3 cells using [3H]-labeled myristate and [3H]-labeled
palmitate. Incorporation of both fatty acids into HASPB-N18-
GFP can be detected in both wild-type and K3 cells whereas
the corresponding negative controls are either labeled only with
[3H]myristate (in the case of HASPB-N18-GFP-∆palm) or not
labeled at all (for HASPB-N18-GFP-∆myr/palm and GFP)
(Fig. 7C). These experiments demonstrate that HASPB-N18-
GFP processing in terms of acylation occurs normally in the
CHO K3 mutant cell line and, therefore, the lack of HASPB-
N18-GFP present on the cell surface of these cells must be due
to the translocation machinery itself from which at least one
component is apparently disrupted in K3 cells.
HASPB-N18-GFP localizes to the plasma membrane in
CHO K3 cells
In order to define the subcellular site of HASPB-N18-GFP
membrane translocation, we analyzed its localization in CHO
wild-type cells versus CHO K3 cells using confocal
microscopy and subcellular fractionation. There was virtually
no difference in the subcellular distribution of HASPB-N18-
GFP in the two cell types and in both cases the majority of the
material is localized to the plasma membrane (Fig. 8A,B).
Fig. 6. Characterization of HASPB-N18-GFP export from CHO wild-type cells compared
to CHO K3 mutant cells. (A) FACS analysis. CHO wild-type cells and CHO K3 cells were
grown for 48 hours at 37°C in the presence of doxicycline (1 µg/ml). Cells were processed
for FACS sorting using affinity-purified anti-GFP antibodies and APC-coupled secondary
antibodies to detect exported HASPB-N18-GFP by cell surface staining. For a statistical
analysis of four independent experiments, GFP-derived fluorescence and APC-derived cell
surface staining of CHO wild-type cells expressing HASPB-N18-GFP was set to 100%,
respectively. (B) Biochemical analysis of exported HASPB-N18-GFP in CHO wild-type
cells, CHO K3 cells and various control cell lines introduced in Figs 1-4 using cell surface
biotinylation. The experiment was conducted exactly as described in the Materials and
Methods and in the legend to Fig. 4. Input material (lane 1; 2%), streptavidin supernatant
(non-biotinylated proteins, lane 2; 2%) and streptavidin-bound proteins (biotinylated
proteins, lane 3; 50%) were separated on SDS gels followed by western blotting using
affinity-purified anti-GFP antibodies.Jo
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These morphological data could be confirmed by a biochemical
analysis employing subcellular fractionation (Fig. 8C). A
protocol to purify plasma membrane vesicles (Schäfer et al.,
2004) was used to compare the enrichment of the HASPB-
N18-GFP reporter molecule in plasma membranes of CHO
wild-type cells (Fig. 8C, lanes 1-4) and CHO K3 cells
(Fig. 8C, lanes 5-8), respectively. When compared to the
homogenate (lanes 1), HASPB-N18-GFP (lane 5) was found
to be enriched in gradient-purified plasma membrane vesicles
using the plasma membrane marker transferrin receptor (TfR)
(Futter et al., 1998) in both CHO wild-type and CHO K3 cells
(lanes 4 and 8, respectively). Using the Golgi marker GM130
(Nakamura et al., 1995), the plasma membrane vesicle fraction
was depleted of Golgi membranes demonstrating the
significance of the findings described above. The association
of HASPB-N18-GFP with plasma membranes in both CHO
wild-type cells and K3 cells is considered to be quite striking
as it demonstrates a defect in CHO K3 cells directly in the
translocation machinery rather than some kind of intracellular
segregation of HASPB-N18-GFP that prevents access to the
site of membrane translocation. Thus, the HASPB-N18-GFP
translocation apparatus is a plasma membrane-resident
machinery.
A FGF-2-GFP reporter molecule is exported from CHO
wild-type and K3 mutant cells at similar levels
In order to analyze whether the disrupted export component in
CHO K3 cells is a specific factor for HASPB export or rather
a general component for non-classical secretory processes,
we tested whether FGF-2, as a classical example for
unconventional secretory proteins (Nickel, 2003), is exported
from CHO K3 cells. For this purpose, we transduced both CHO
K3 and the parental CHO wild-type cells expressing the
HASPB-N18-GFP fusion protein with retroviral particles
encoding a FGF-2-GFP fusion protein (Engling et al., 2002;
Backhaus et al., 2004). Owing to the different molecular
weights (25 and 45 kDa, respectively), the two reporter
molecules could be easily distinguished in the cell surface
biotinylation assay (Figs 4 and 6). There was no difference in
FGF-2 cell surface expression between CHO wild-type and
CHO K3 cells (Fig. 9, compare lanes 3 and 6; upper panels),
respectively. By contrast, HASPB-N18-GFP analyzed from the
same cell preparations is exported only from CHO wild-type
cells (compare lanes 3 and 6; lower panels). These results
demonstrate that the component disrupted in CHO K3 cells is
a specific machinery molecule of the HASPB export pathway.
Discussion
The specific aim of this study was to develop an experimental
approach designed to identify the subcellular membrane
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Fig. 7. Expression level, membrane association and post-translational
acylation of HASPB-N18-GFP in CHO wild-type cells and CHO
mutant K3 cells. (A) CHO wild-type cells and CHO K3 cells (both
expressing HASPB-N18-GFP) were grown on six-well plates to
about 80% confluency in the absence (lane 1) or presence (lane 2) of
doxicycline (1 µg/ml) for 48 hours at 37°C. Cells were detached with
PBS/EDTA, collected by centrifugation and lysed in SDS sample
buffer. 1% of each lysate corresponding to cells from one well were
subjected to SDS-PAGE. HASPB-N18-GFP was detected by western
blotting using affinity-purified anti-GFP antibodies. (B) CHO wild-
type cells and CHO K3 cells (both expressing HASPB-N18-GFP)
were grown on six-well plates to about 80% confluency in the
presence of 1 µg/ml doxicycline for 48 hours at 37°C. Subcellular
fractionation and carbonate extraction of membranes was performed
and 5% of each fraction was combined with SDS sample buffer and
proteins were separated by SDS-PAGE. Following western blotting,
HASPB-GFP fusion proteins were detected with affinity-purified
anti-GFP antibodies. (C) CHO wild-type cells, CHO K3 cells (both
expressing HASPB-N18-GFP) as well as control cell lines
expressing HASPB-N18-GFP ∆myr/palm and HASPB-N18-GFP
∆palm, respectively, were grown on six-well plates to about 80%
confluency in the presence of 1 µg/ml doxicycline for 48 hours at
37°C and labelled with [3H]myristate and [3H]palmitate. Cell lysates
were prepared and subjected to immunoprecipitation using affinity-
purified anti-GFP antibodies. Immunopurified fractions were split
into two samples, separated on SDS gels and either processed by
fluorography (upper panel) or silver staining (lower panel).
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system that contains the molecular machinery required for cell
surface expression of Leishmania HASPB in mammalian cells.
This question is of general interest because, during its
biogenesis, HASPB has been shown to contact intracellular
membranes such as the Golgi (Denny et al., 2000). Based on
the evidence currently available, the most logical explanation
for this observation is that Golgi membranes contain the
palmitoylacyltransferase required for the thioester-based
acylation of cysteine 5 in the N-terminal SH4 domain of
HASPB. From this point on, it is not clear whether fully
acylated HASPB translocates across the membrane of the
Golgi or whether it is first transported to the plasma membrane
associated with the cytoplasmic leaflet of secretory vesicles.
Even though overall cell surface expression of HASPB has
been shown not to be affected by brefeldin A (Denny et al.,
2000), this result does not unequivocally rule out the possibility
that HASPB is traveling to the plasma membrane associated
with the cytoplasmic leaflet of TGN-derived secretory vesicles.
It is also possible that transfer to the plasma membrane
involves an intermediate step in which HASPB is not at all
associated with intracellular membranes or HASPB might be
transported from the TGN to the endosomal system from where
it might get access to the plasma membrane.
Based on the uncertainties discussed above, we were
interested in establishing an experimental system that allows
for a quantitative analysis of HASPB cell surface expression
under conditions where defined steps in HASPB biogenesis are
blocked. In particular, we were looking for experimental
conditions where dual acylation of the N-terminal SH4 domain
of HASPB occurs normally but HASPB export to the outer
leaflet of the plasma membrane is blocked. In this context, we
decided to use CHO cells as a model system as they are well
suited to the generation of random somatic mutants. To
Fig. 8. Subcellular localization of HASPB-N18-GFP in CHO wild-
type and CHO K3 mutant cells as determined by confocal
microscopy and subcellular fractionation. (A) HASPB-N18-GFP
expressed in CHO wild-type cells. (B) HASPB-N18-GFP expressed
in CHO K3 mutant cells. Cells were grown on glass coverslips in the
presence of 1 µg/ml doxicycline for 48 hours at 37°C and processed
for confocal microscopy. GFP-derived fluorescence was viewed with
a Zeiss LSM 510 confocal microscope. (C) Subcellular fractionation
of CHO wild-type cells and CHO K3 cells was conducted as
described earlier (Schäfer et al., 2004). To identify plasma
membranes, antibodies directed against the transferrin receptor were
used (Futter et al., 1998). To detect Golgi membranes, antibodies
directed against GM130 were used (Nakamura et al., 1995). Four
fractions were generated and analyzed for each cell line: a hypotonic
lysate (lanes 1 and 5), a post-mitochondrial supernatant (lanes 2 and
6), a microsomal membrane fraction (lanes 3 and 7) and gradient-
purified plasma membranes (lanes 4 and 8). For each fraction 15 µg
total protein were loaded per lane followed by SDS-PAGE and
western blotting using the antibodies indicated.
Fig. 9. Secretion of FGF-2 from CHO K3 cells occurs as efficiently
as from parental CHO wild-type cells. Parental CHO wild-type
(lanes 1-3) and CHO K3 mutant cells (lanes 4-6) expressing HASPB-
N18-GFP were transduced with retroviral particles containing the
FGF-2-GFP open reading frame controlled by a doxicycline-
dependent element. Transduction efficiency was about 65% as
determined by GFP-derived fluorescence. Both cell types were
treated with a membrane-impermeable biotinylation reagent. Cell
lysates were generated and biotin-labeled and biotin-unlabeled
proteins were separated by streptavidin affinity chromatography.
Input material (lane 1 and 4; 4%), streptavidin supernatant (non-
biotinylated proteins, lanes 2 and 5; 4%) and streptavidin-bound
proteins (biotinylated proteins, lanes 3 and 6; 50%) were separated
on SDS gels followed by western blotting using affinity-purified anti-
GFP antibodies.
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efficiently mutate CHO cells expressing HASPB-N18-GFP in
a doxicycline-dependent manner, we used retroviral insertion
mutagenesis with CD4 as a cell surface marker to efficiently
enrich mutated cells by FACS. Using the FACS-based
experimental system described, we succeeded in isolating
clonal CHO mutants with the desired phenotype, one of which
has been characterized in detail in the current study.
In the described CHO mutant strain (K3), HASPB-N18-GFP
is expressed in a doxicycline-dependent manner at a level
comparable to that of wild-type cells. In the context of this
work, it was most critical to isolate CHO mutants that do not
have any defect in the co- and/or post-translational processing
of HASPB, i.e. we were looking for mutants that are still
capable of adding both myristate and palmitate to the SH4
domain of HASPB. In the case of CHO K3 cells, this was
shown to be the case by carbonate extraction experiments to
probe overall membrane association of HASPB-N18-GFP as
well as metabolic labeling experiments to demonstrate directly
the incorporation of [3H]-labeled myristate and palmitate into
HASPB-N18-GFP when expressed in CHO K3 cells. These
experiments unequivocally demonstrated that HASPB-N18-
GFP is processed normally in CHO K3 mutant cells resulting
in a membrane association that is indistinguishable from
HASPB-N18-GFP expressed in CHO wild-type cells.
The negative HASPB-N18-GFP export phenotype by which
the clonal CHO K3 cell line was isolated could be confirmed
by both FACS-based cell surface staining experiments and a
biochemical assessment of HASPB-N18-GFP export using a
membrane-impermeable biotinylation reagent. Both methods
consistently demonstrated that HASPB-N18-GFP cell surface
expression in CHO K3 cells is greatly reduced to ~10-30% of
the population found on the cell surface of CHO wild-type
cells. As the expression level of HASPB-N18-GFP does not
differ significantly between CHO K3 and wild-type cells, as
shown by both western blotting and GFP-derived fluorescence
determined by FACS, we conclude that the process of HASPB-
N18-GFP membrane translocation is perturbed in the mutant
cell line. Based on this observation, it was then crucial to
analyze whether the steady-state distribution of the reporter
molecule is changed in CHO K3 cells as compared to wild-
type cells. As demonstrated by confocal microscopy and
subcellular fractionation, this is not the case as the majority of
the HASPB-N18-GFP population localizes in both cell lines to
the plasma membrane. Intriguingly, a FGF-2-GFP fusion
protein is secreted equally well from the CHO K3 mutant cell
line and the parental CHO wild-type cells, demonstrating that
the disrupted factor in K3 cells is a specific component of the
HASPB export pathway.
From the combined data presented in this study, we conclude
that the CHO mutant cell line K3 has a direct defect in the
molecular machinery promoting membrane translocation of
HASPB. The subcellular distribution of the reporter molecule
is unchanged when wild-type and K3 mutants cells are
compared, with HASPB-N18-GFP detected in both cases as a
plasma membrane-resident protein. As cell surface exposure of
the reporter is largely reduced in the mutant cell line, we
conclude that the plasma membrane is the subcellular site of
membrane translocation of HASPB-N18-GFP. Thus, along
with the angiogenic growth factors FGF-1 and FGF-2
(Prudovsky et al., 2002; Schäfer et al., 2004), HASPB
represents another example of an unconventional secretory
protein that is translocated directly across the plasma
membrane of mammalian cells in order to be exposed to the
extracellular space. Our data allow us to describe a two-step
process for the overall biogenesis of HASPB that is defined by
acylation-dependent targeting to the inner leaflet of the plasma
membrane followed by translocation across the plasma
membrane, resulting in a membrane-anchored lipoprotein on
the surface of both parasites and mammalian cells.
The experimental approach presented in this study shows
great promise for addressing a number of questions related to
HASPB biogenesis in the future. In this regard, our goals are not
restricted to the molecular analysis of the HASPB membrane
translocation apparatus itself but also concern the preceding
steps such as the molecular identity and the exact subcellular
localization of the HASPB palmitoylacyltransferase. Moreover,
it remains a completely open question how HASPB is
transferred from the Golgi to the plasma membrane. As the
experimental approach described gave rise to a whole collection
of CHO mutant cell lines characterized by a negative HASPB
export phenotype, we hope to also identify mutants that are
defective in early steps of HASPB biogenesis. The most
important future goal will be to look for the defective genes by
functional expression cloning and/or genome insertion analysis
of the retrovirus used as a mutagen as well as to assign the
corresponding gene products to defined steps of the HASPB
biogenesis pathway on a functional basis.
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